Implications of the Business Strategies of Pharmaceutical Companies for Industry Developments in Australia

105 641 2137 4 1056 document 2137 wp1_2002_pharma.pdf application/pdf 54161 2011-09-09 10:19:49 https://vuir.vu.edu.au/105/1/wp1_2002_pharma.pdf 105 1 application/pdf text en public

wp1_2002_pharma.pdf

http://eprints.org/relation/hasVolatileVersion https://vuir.vu.edu.au/id/document/10932 http://eprints.org/relation/hasVersion https://vuir.vu.edu.au/id/document/10932 http://eprints.org/relation/hasIndexCodesVersion https://vuir.vu.edu.au/id/document/10932 10932 3 1735171 document 10932 indexcodes.txt text/plain 9dad563127a3f2f7cdd5389fc4c0e2de MD5 10535 2013-02-06 18:21:49 https://vuir.vu.edu.au/105/2/indexcodes.txt 105 2 2 text/plain other Generate index codes conversion from application/pdf to indexcodes en public

indexcodes.txt

http://eprints.org/relation/isVersionOf https://vuir.vu.edu.au/id/document/2137 http://eprints.org/relation/isVolatileVersionOf https://vuir.vu.edu.au/id/document/2137 http://eprints.org/relation/isIndexCodesVersionOf https://vuir.vu.edu.au/id/document/2137 59679 2 2392130 document 59679 lightbox.jpg image/png 80f31d61518beef9ae10082a80cf5678 MD5 54452 2020-08-13 00:36:01 https://vuir.vu.edu.au/105/4/lightbox.jpg 105 4 4 image/png other Thumbnails conversion from text to thumbnail_lightbox en staffonly

lightbox.jpg

preview.jpg

medium.jpg

small.jpg

http://eprints.org/relation/isVersionOf https://vuir.vu.edu.au/id/dark_document/59666 http://eprints.org/relation/isVolatileVersionOf https://vuir.vu.edu.au/id/dark_document/59666 http://eprints.org/relation/issmallThumbnailVersionOf https://vuir.vu.edu.au/id/dark_document/59666 archive 34 disk0/00/00/01/05 2005-10-21 2021-08-27 07:38:37 2008-08-19 18:54:20 monograph show Rasmussen Bruce 0000-0001-5779-0339 Implications of the Business Strategies of Pharmaceutical Companies for Industry Developments in Australia pub 320000 FOR_2008_111500 cses pharmaceutical industry; biotechnology; technological advances; business strategies of pharmaceutical companies; Australia; competition The pharmaceutical industry is highly complex. The technologies leading to drug discovery and development are at the limits of human knowledge. The huge size of the companies and the complexities of their processes and technologies presents many organisational and management challenges. The development and management of the distribution system is highly costly. However while excellence in managing all these aspects of the industry is a necessary condition for the survival of the global pharmaceutical companies, the uncertainty of the discovery process and the potentially huge returns from the discovery of a single drug means that like drilling for oil or randomly choosing the black beans from a jar of overwhelmingly white ones, success in the industry depends on a high measure of luck. Much of the thinking about business strategy in the industry is how best to cope with this uncertainty. This has not always been the case. Colonel Ely Lilly gained his initial competitive advantage, in manufacturing, by producing 'true to label' products in competition with the various 'snake oils' and other dubious concoctions of the era. 2002-03 published Victoria University No. 1 59666 2 2392107 dark_document 59666 Rasmussen Bruce.pdf application/pdf c744ba1adbaf7053dda5f38299888596 MD5 107419 2020-08-13 00:25:44 105 3 3 application/pdf text Submission & Permission Form en staffonly

Rasmussen Bruce.pdf

other public working_paper Melbourne, Australia 13 Victoria University Centre for Strategic Economic Studies FALSE